1. Home
  2. BGR vs XOMA Comparison

BGR vs XOMA Comparison

Compare BGR & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Energy and Resources Trust

BGR

BlackRock Energy and Resources Trust

HOLD

Current Price

$16.34

Market Cap

417.7M

Sector

Finance

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$41.82

Market Cap

471.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGR
XOMA
Founded
2004
1981
Country
United States
United States
Employees
N/A
14
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.7M
471.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGR
XOMA
Price
$16.34
$41.82
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$52.50
AVG Volume (30 Days)
98.8K
374.8K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
6.02%
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.59
Revenue Next Year
N/A
N/A
P/E Ratio
$23.62
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$22.29
52 Week High
$17.70
$42.81

Technical Indicators

Market Signals
Indicator
BGR
XOMA
Relative Strength Index (RSI) 49.89 68.80
Support Level $16.18 $24.38
Resistance Level $17.00 $42.41
Average True Range (ATR) 0.27 0.86
MACD -0.03 -0.30
Stochastic Oscillator 45.67 82.70

Price Performance

Historical Comparison
BGR
XOMA

About BGR BlackRock Energy and Resources Trust

BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains, and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials, utilities, and others.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

Share on Social Networks: